These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10862524)

  • 1. The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients.
    Suzuki A; Mihara K; Kondo T; Tanaka O; Nagashima U; Otani K; Kaneko S
    Pharmacogenetics; 2000 Jun; 10(4):335-41. PubMed ID: 10862524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients.
    Suzuki A; Kondo T; Mihara K; Yasui-Furukori N; Ishida M; Furukori H; Kaneko S; Inoue Y; Otani K
    Pharmacogenetics; 2001 Aug; 11(6):545-50. PubMed ID: 11505224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients.
    Suzuki A; Kondo T; Mihara K; Furukori H; Nagashima U; Ono S; Otani K; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Oct; 24(7):1105-13. PubMed ID: 11131175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report.
    Suzuki A; Kondo T; Mihara K; Yasui-Furukori N; Otani K; Furukori H; Kaneko S; Inoue Y
    Eur Arch Psychiatry Clin Neurosci; 2001; 251(2):57-9. PubMed ID: 11407439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene.
    Mihara K; Kondo T; Suzuki A; Yasui N; Nagashima U; Ono S; Otani K; Kaneko S
    Psychopharmacology (Berl); 2000 Apr; 149(3):246-50. PubMed ID: 10823405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No relationship between Taq1 a polymorphism of dopamine D(2) receptor gene and extrapyramidal adverse effects of selective dopamine D(2) antagonists, bromperidol, and nemonapride in schizophrenia: a preliminary study.
    Mihara K; Suzuki A; Kondo T; Nagashima U; Ono S; Otani K; Kaneko S
    Am J Med Genet; 2000 Jun; 96(3):422-4. PubMed ID: 10898926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia.
    Sakumoto N; Kondo T; Mihara K; Suzuki A; Yasui-Furukori N
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):174-80. PubMed ID: 17362435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol.
    Mihara K; Suzuki A; Kondo T; Yasui-Furukori N; Ono S; Otani K; Kaneko S; Inoue Y
    Am J Med Genet; 2001 Apr; 105(3):271-4. PubMed ID: 11353448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of dopamine D2 receptor gene polymorphisms as a possible predictor of treatment-resistance to dopamine antagonists in schizophrenic patients.
    Kondo T; Mihara K; Suzuki A; Yasui-Furukori N; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):921-6. PubMed ID: 14499308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.
    Thompson J; Thomas N; Singleton A; Piggott M; Lloyd S; Perry EK; Morris CM; Perry RH; Ferrier IN; Court JA
    Pharmacogenetics; 1997 Dec; 7(6):479-84. PubMed ID: 9429233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
    Miura I; Takeuchi S; Katsumi A; Mori A; Kanno K; Yang Q; Mashiko H; Numata Y; Niwa S
    J Clin Psychopharmacol; 2012 Feb; 32(1):106-9. PubMed ID: 22198450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No relationship between--141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary study.
    Mihara K; Kondo T; Suzuki A; Yasui N; Ono S; Otani K; Kaneko S
    Psychiatry Res; 2001 Feb; 101(1):33-8. PubMed ID: 11223117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients.
    Wu S; Xing Q; Gao R; Li X; Gu N; Feng G; He L
    Neurosci Lett; 2005 Mar; 376(1):1-4. PubMed ID: 15694263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.
    Alenius M; Wadelius M; Dahl ML; Hartvig P; Lindström L; Hammarlund-Udenaes M
    J Psychiatr Res; 2008 Sep; 42(11):884-93. PubMed ID: 18086475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined effect of CYP2D6 and DRD2 Taq1A polymorphisms on the antipsychotics daily doses and hospital stay duration in schizophrenia inpatients (observational naturalistic study).
    Kurylev AA; Brodyansky VM; Andreev BV; Kibitov AO; Limankin OV; Mosolov SN
    Psychiatr Danub; 2018 Jun; 30(2):157-163. PubMed ID: 29930225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage and association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population.
    Behravan J; Hemayatkar M; Toufani H; Abdollahian E
    Arch Iran Med; 2008 May; 11(3):252-6. PubMed ID: 18426314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene.
    Laruelle M; Gelernter J; Innis RB
    Mol Psychiatry; 1998 May; 3(3):261-5. PubMed ID: 9672902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small.
    Berggren U; Fahlke C; Aronsson E; Karanti A; Eriksson M; Blennow K; Thelle D; Zetterberg H; Balldin J
    Alcohol Alcohol; 2006; 41(5):479-85. PubMed ID: 16751215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.
    Zhang JP; Lencz T; Malhotra AK
    Am J Psychiatry; 2010 Jul; 167(7):763-72. PubMed ID: 20194480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic spectrum of nemonapride and its relationship with plasma concentrations of the drug and prolactin.
    Kondo T; Mihara K; Yasui N; Nagashima U; Ono S; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Otani K
    J Clin Psychopharmacol; 2000 Aug; 20(4):404-9. PubMed ID: 10917400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.